Coverage View And Valuation Gate
Growth-investment verdict: VIAV is an attractive watchlist name, but not a completed growth investment underwrite at the current price. Fundamentals snapshot: Q3 FY26 revenue was $406.8M, non-GAAP EPS was $0.27, Q4 guidance points to another sequential step-up, and pro forma enterprise value is roughly $12.43B after the May 2026 equity raise and planned term-loan repayment.
Decision hinge
Whether the Spirent and Inertial Labs assets can make VIAV a durable data-center and aerospace test compounder rather than a cyclical telecom test rebound with one-time acquisition lift.
What appears priced in
At roughly 8.2x FY2026 sales and 53.4x FY2026 adjusted earnings, the stock is already asking for FY2027 growth, integration synergy, and better cash conversion.
What kills the thesis
Data-center test demand fades, Spirent revenue is less recurring than expected, optical-security mix stays unfavorable, or operating cash flow lags non-GAAP earnings after integration and restructuring.
Capital Return And Funding Gate
This gate is central because VIAV used acquisition funding, convertible-note settlements, a new term loan, and then a May 2026 equity offering. The equity story cannot rely on a simple revenue multiple without a fully diluted and cash-flow-normalized bridge.
| Item | Reported / pro forma input | Evidence label | Underwriting implication |
|---|---|---|---|
| Cash, short-term investments and restricted cash | $508.0M at March 28, 2026 | Verified fact | Liquidity was adequate, but only 34.1% of cash was at U.S. subsidiaries per the 10-Q. |
| Debt before offering | About $1100.0M principal; $1080.8M carrying value | Verified fact | Leverage rose after acquisitions and convertible-note activity. |
| May 2026 equity offering | 12.78M primary shares including full option; $557.2M estimated net proceeds | Verified fact | Dilution is the cost of balance-sheet repair. |
| Term Loan B repayment | $450.0M planned repayment | Verified fact / company intent | Reduces interest burden but does not prove cash conversion. |
| Pro forma net debt | Roughly $34.8M net debt after offering and planned repayment | Model-derived | Balance sheet looks less binding, but share count and Q4 cash movement still need confirmation. |
| No share repurchase in Q3 FY26 | Company prioritized debt management | Company claim | Capital allocation shifted from buyback support to balance-sheet repair. |
Thesis Pillars
1. Data-center test demand is now material enough to change the growth profile.
VIAV's fiscal Q3 revenue rose 42.8% year over year, with Network and Service Enablement revenue at $321.5M, up 54.4%. The Spirent asset acquisition added high-speed Ethernet, network security and channel emulation exposure. S1/S9/S11
Monitor: NSE revenue growth, book-to-bill commentary, and customer concentration in hyperscale or AI infrastructure demand.
2. Aerospace and defense can help reduce telecom cyclicality, but the evidence is still early.
Inertial Labs adds positioning, navigation and timing exposure, and management continues to call out aerospace and defense as growth applications. The issue is not strategic fit; it is whether revenue quality and margins justify acquisition and contingent consideration. S8/S10
Monitor: PNT backlog, defense program timing, gross margin mix, and contingent-liability remeasurement.
3. OSP remains high-margin ballast, not the core re-rate engine.
Optical Security and Performance Products produced $85.3M of Q3 FY26 revenue and 35.3% operating margin, but gross margin slipped year over year from unfavorable product mix. S1/S2
Monitor: anti-counterfeiting volume, 3D sensing demand, and whether OSP mix offsets or amplifies NSE cyclicality.
4. Adjusted earnings are improving faster than reported earnings and cash flow.
Q3 non-GAAP EPS was $0.27, but GAAP EPS was $0.03 and operating cash flow was negative in the quarter, partly due to contingent consideration. That gap is acceptable during integration only if it closes. S1/S2
Monitor: free cash flow, stock-based compensation, restructuring cash spend, inventory, and acquisition-related adjustments.
Eight-quarter Revenue And Earnings Chart
Past six reported quarters plus guidance and estimate
Revenue and non-GAAP earnings per share with visible year-over-year growth rates.
Growth Estimates Consensus
Accessible consensus covers FY2026 and FY2027; FY2028 is an explicit scenario assumption because the public detailed FY2028 table is not fully visible without provider access. United States dollars are used throughout. Currency conversion note: no exchange-rate conversion was required because source currency is United States dollars.
Three-year growth estimates consensus and scenario
FY2026-FY2027 use accessible consensus or guidance; FY2028 is labeled as a model assumption.
| Year | Revenue | Revenue growth | Adjusted EPS | EPS growth | Source treatment |
|---|---|---|---|---|---|
| FY2025 actual | $1084.3M | +8.4% | $0.47 | +42.4% | Company reported non-GAAP EPS |
| FY2026 consensus / guide | $1507.2M | +39.0% | $0.94 | +99.4% | First 3 quarters plus Q4 guide midpoint; matches accessible consensus |
| FY2027 consensus | $1790.0M | +18.8% | $1.28 | +36.6% | StockAnalysis / S&P Global estimate context |
| FY2028 scenario | $2060.0M | +15.1% | $1.58 | +23.4% | Assumption because detailed public FY2028 revenue/EPS table is not fully visible |
Valuation And Scenario Frame
Base case
FY2026 revenue of about $1.51B and adjusted EPS of $0.94, with Q4 guide midpoint reached. At $50.24, VIAV trades near 53.4x FY2026 adjusted earnings.
Upside case
FY2027 revenue reaches roughly $1.79B and adjusted EPS reaches $1.28, with acquired assets proving durable and OSP margin stabilizing. That still leaves VIAV at about 39.3x FY2027 adjusted earnings.
Downside mechanism
The market capitalizes acquisition-aided growth at too high a multiple, while cash conversion and dilution lag. The stock can de-rate even if revenue continues to grow.
Backup method: EV/sales is useful market context but not sufficient for a target price until the pro forma capitalization, interest savings, restructuring savings, and after-financing free cash flow are tied out.
Company Description And Industry Position
What the company does
VIAV sells test, monitoring, assurance and optical technologies used by communications service providers, network equipment makers, cloud/data-center customers, aerospace and defense users, first responders, industrial customers and anti-counterfeiting customers. The long-term growth products are high-speed Ethernet testing, network security testing, channel emulation, wireless validation, resilient positioning/navigation/timing, and specialty optical-security products.
Competitive comparison
The company is smaller than Keysight but now has a more targeted position in Ethernet, network security, channel emulation, wireless, field test, PNT and optical-security niches. Its public equity appeal is narrower and more cyclical than a broad test-and-measurement leader.
Key Debates And Variant Perception
| Debate | Consensus / market view | Variant view | Next evidence |
|---|---|---|---|
| Data-center cycle | Revenue acceleration proves a durable AI infrastructure test cycle. | Some growth may be acquired and cyclical; durability needs backlog and repeat-order evidence. | Q4 FY26 and FY27 guide, customer mix, NSE organic growth. |
| Margin quality | Non-GAAP operating margin above 20% shows operating leverage. | GAAP earnings and cash flow still lag due to amortization, restructuring, contingent consideration and integration costs. | FCF margin and adjusted-to-GAAP bridge through FY2027. |
| Capital structure | Equity raise reduced debt risk. | Debt repayment helps, but dilution and pro forma share count must be built into valuation. | Post-offering share count, interest expense run-rate, convertible treatment. |
| Valuation | Sell-side targets imply upside to the mid-$60s. | The stock already prices a lot of the FY2027 EPS path; the model needs an explicit downside case. | Estimate revisions after Q4 FY26 and FY2027 guidance. |
Catalysts, Risks, And Falsifiers
Catalysts
Q4 FY26 earnings, FY2027 guide, evidence of Spirent cross-sell, aerospace/defense program traction, interest savings after term-loan repayment, and sustained data-center test demand.
Risks
Integration shortfall, telecom spending relapse, customer concentration, tariff and supply-chain costs, unfavorable OSP mix, contingent consideration cash leakage, and high multiple sensitivity.
Falsifiers
NSE growth slows below the FY2027 consensus path, free cash flow stays negative after integration, or GAAP earnings remain structurally weak relative to adjusted earnings.
Source Register, Conflicts, Assumptions, Open Evidence
| ID | Source | Type | Date | Coverage | Confidence | Use |
|---|---|---|---|---|---|---|
| S1 | VIAVI fiscal Q3 2026 earnings release | Company release | Apr. 29, 2026 | Q3 FY26 and Q4 FY26 guide | High | Revenue, non-GAAP EPS, segment revenue, Q4 guidance, cash flow summary. |
| S2 | VIAVI fiscal Q3 2026 Form 10-Q | SEC filing | Apr. 30, 2026 | Quarter ended Mar. 28, 2026 | High | Balance sheet, debt, lease liabilities, liquidity, segment analysis, restructuring. |
| S3 | VIAVI Form 8-K for May 2026 equity offering | SEC filing | May 21, 2026 | Equity offering and term loan repayment plan | High | 12.78 million primary shares including option, $557.2 million net proceeds, planned $450 million term loan repayment. |
| S4 | Google Finance quote page | Market data | Accessed Jun. 12, 2026 | June 11, 2026 market close | Medium | Price, market value, shares outstanding, 52-week range, volume. |
| S5 | StockAnalysis forecast page | Third-party estimates | Last checked Jun. 10, 2026 | FY26-FY27 estimates and price target context | Medium | Revenue, adjusted EPS, analyst price-target context sourced by the site to S&P Global / TipRanks. |
| S6 | MarketBeat earnings page | Third-party estimate recap | Accessed Jun. 12, 2026 | Q3 FY26 beat and Q4 guidance comparison | Medium | Consensus comparison and next earnings date. |
| S7 | VIAVI FY2025 results release | Company release | Aug. 7, 2025 | Q4 FY25 and FY2025 | High | FY2025 actual revenue, segment revenue, non-GAAP EPS, quarterly baseline. |
| S8 | VIAVI Q1 and Q2 FY2026 releases | Company releases | Oct. 29, 2025 and Jan. 28, 2026 | Q1-Q2 FY26 | High | Quarterly revenue, non-GAAP EPS, segment mix, debt and cash context. |
| S9 | VIAVI Spirent asset acquisition close release | Company release | Oct. 16, 2025 | Spirent HSE, network security and channel emulation assets | High | $425 million all-cash acquisition; data-center and network-security test expansion. |
| S10 | VIAVI Inertial Labs acquisition announcement | Company release | Dec. 13, 2024 | Inertial Labs transaction | High | $150 million initial consideration and up to $175 million contingent consideration; PNT/aerospace/defense expansion. |
| S11 | U.S. Department of Justice divestiture statement | Regulator release | 2025 | Keysight / Spirent remedy | High | DOJ required divestiture of high-speed Ethernet, network security, and RF channel emulation assets to VIAVI. |
Unresolved conflicts
Third-party price targets and estimate pages are updating quickly after the re-rate and show some stale values. Use current market data and filings as anchors.
Major assumptions
Pro forma enterprise value assumes current market cap reflects post-offering share count, $557.2M net offering proceeds, and $450M Term Loan B repayment. FY2028 is a scenario, not consensus.
Recommended handoff
Build an equity-model update with organic versus acquired growth, adjusted-to-GAAP reconciliation, pro forma interest expense, fully diluted shares, and FCF bridge; then start thesis-tracker monitoring.